The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a “universal” flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports. As the researchers from Emory University and the University of Chicago report in the Jan. 10 issue of the Journal of Experimental Medicine, “people who were infected with the H1N1 virus and recovered had a special immune response, producing antibodies that protect against a wide variety of flu strains,” the news service writes (1/10).
Also In Global Health News: NGOs, Business Schools; India’s Growing Presence In Africa; Water, Sanitation In Indonesia; Malaria Vaccine Trials
Financial Times Reports On Oxfam’s MBA Workshops Financial Times explores how the NGO Oxfam has started to “develop ethical trade workshops for MBA students in UK business schools, with a particular focus on overseas students” in the “hopes that by targeting the next generation of business leaders, it can influence…
AlertNet posed health, technology, water and other experts questions, such as, “[w]hat cheap, low-tech innovations could be used to improve the lives of the poor? Which potentially life-saving ideas have been knocking around for years but still aren’t widely practised?”
On Friday, the Office of the U.N. Special Envoy to Haiti said that 63.6 percent of the aid international donors “pledged to Haiti in 2010 after a devastating earthquake nearly one year ago” has been disbursed, Deutsche Presse-Agentur/M&C reports (1/7).
“Among HIV-negative sexual partners, male circumcision helps prevent the transmission of human papillomavirus [HPV] from men to women,” according to a study published online Thursday in the Lancet, HealthDay News/Bloomberg Businessweek reports. “However, circumcision offers only partial protection and partners must still practice safe sex, the researchers pointed out,” according to the news service (1/6).
Also In Global Health News: Vaccination Hampered In Cote d’Ivoire; TB And Lung Cancer; HIV Testing, Counseling In Zambia; Reducing Child, Maternal Mortality In Ghana; Male Circumcision Campaign In Kenya
Political Unrest Hampering Cote d’Ivoire’s Yellow Fever Vaccine Campaign “Unrest following Cote d’Ivoire’s presidential election is blocking a nationwide vaccination drive against yellow fever, a fatal mosquito-borne disease that is affecting people throughout the country,” IRIN reports. The immunization campaignÂ â€“ part of a global effort by WHO and UNICEF â€“…
Also In Global Health News: UK’s Global TB Control Program; Yellow Vaccine Scarcity In Uganda; Rats Detecting TB; Volunteer Health Workers In Afghanistan; Cuba’s Health System
Paper Criticizes UK’s Global Approach To TB Control A paper published in the Journal of the Royal Society of Medicine highlights concern about the U.K. Department of International Development’s (DfID)Â global tuberculosis control strategy, the Guardian reports. “Bruce Currey, Professor Quazi Quamruzzaman and Professor Mahmuder Rahman, all based at Dhaka Community…
Also In Global Health News: Field Trial To Fight Dengue In Australia; Bangladesh Reducing Child Mortality; Yellow Fever In Uganda; HIV/AIDS In Iran
Dengue-Blocking Mosquitoes Field Trial To Kick Off Tuesday In Australia AAP/Sydney Morning Herald reports that a 12-week field trial involving the release of mosquitoes infected with a bacterium known to block the transmission of dengue will kick off Tuesday in several suburbs in north Queensland, Australia. “Laboratory research has shown…
The Problem With A ‘Robo Budget': In a post on “The Hill’s Congress Blog,” Senator Patrick Leahy, (D-Vt.), writes about the recent defeat of the omnibus bill, calling the passage of a continuing resolution a “robo budget” that is a “disservice.” According to Leahy: “The Omnibus would have funded global…
The New York Times examines the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, which gave a total of $450 million to 43 research projects over five years. “On drawing attention to ways that lives might be saved through scientific advances, I’d give us an A,” Bill Gates, co-founder of the foundation, said of the program in an interview with the newspaper. “But I thought some would be saving lives by now, and it’ll be more like in 10 years from now,” Gates said.